Updated Jul 16, 2026
Connaughton Alan B. has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Alan B. Connaughton is the Chief Operating Officer of LENSAR, Inc., a commercial-stage medical device company focused on developing a femtosecond laser system for cataract treatment. In this role, he leads day-to-day operations, including manufacturing, supply chain, and overall operational execution to support the LENSAR Laser System product line.
| Role | Insider |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | LNSR | LENSAR, Inc. | A — Grant or award | 34.8K | $0.00 | |
| 2026-05-08 | LNSR | LENSAR, Inc. | F — Tax withholding / forfeiture | 2.7K | $5.38 | $15K |
| 2026-02-20 | LNSR | LENSAR, Inc. | F — Tax withholding / forfeiture | 2.4K | $11.32 | $27K |
| 2026-01-13 | LNSR | LENSAR, Inc. | F — Tax withholding / forfeiture | 2.3K | $11.57 | $26K |
Alan B. Connaughton is the Chief Operating Officer of LENSAR, Inc., a commercial-stage medical device company focused on developing a femtosecond laser system for cataract treatment. In this role, he leads day-to-day operations, including manufacturing, supply chain, and overall operational execution to support the LENSAR Laser System product line.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Connaughton Alan B. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.